Clinical Trial Update: Study of VEGF-A Targeting NIR-II Fluorescence Endoscopy in the Gastrointestinal Tract [Phase 1]

View source ↗

Summary

Phase 1 study evaluating VEGF-A targeting NIR-II fluorescence endoscopy for GI tract imaging is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Gastrointestinal Dysplasia
• Gastrointestinal Polyps

Snippet

Sponsor: Institute of Automation, Chinese Academy of Sciences | Conditions: Gastrointestinal Carcinoma, Dysplasia | Phase 1 | Status: RECRUITING